vs
HAEMONETICS CORP（HAE）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
RBC Bearings INC的季度营收约是HAEMONETICS CORP的1.4倍（$461.6M vs $339.0M），RBC Bearings INC净利率更高（14.6% vs 13.2%，领先1.4%），RBC Bearings INC同比增速更快（17.0% vs -2.7%），RBC Bearings INC自由现金流更多（$99.1M vs $87.2M），过去两年RBC Bearings INC的营收复合增速更高（5.6% vs 0.4%）
豪洛捷（Haemonetics）是全球血液与血浆供应及服务提供商，于20世纪70年代由艾伦·（杰克）·莱瑟姆博士在马萨诸塞州内蒂克创立，业务围绕血液相关产品及配套服务展开，为全球医疗领域提供血液管理相关的专业解决方案。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
HAE vs RBC — 直观对比
营收规模更大
RBC
是对方的1.4倍
$339.0M
营收增速更快
RBC
高出19.8%
-2.7%
净利率更高
RBC
高出1.4%
13.2%
自由现金流更多
RBC
多$11.9M
$87.2M
两年增速更快
RBC
近两年复合增速
0.4%
损益表 — Q3 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $339.0M | $461.6M |
| 净利润 | $44.7M | $67.4M |
| 毛利率 | 59.7% | 44.3% |
| 营业利润率 | 19.9% | 22.3% |
| 净利率 | 13.2% | 14.6% |
| 营收同比 | -2.7% | 17.0% |
| 净利润同比 | 19.3% | 16.4% |
| 每股收益（稀释后） | $0.95 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HAERBC
| Q4 25 | $339.0M | $461.6M | ||
| Q3 25 | $327.3M | $455.3M | ||
| Q2 25 | $321.4M | $436.0M | ||
| Q1 25 | $330.6M | $437.7M | ||
| Q4 24 | $348.5M | $394.4M | ||
| Q3 24 | $345.5M | $397.9M | ||
| Q2 24 | $336.2M | $406.3M | ||
| Q1 24 | — | $413.7M |
净利润HAERBC
| Q4 25 | $44.7M | $67.4M | ||
| Q3 25 | $38.7M | $60.0M | ||
| Q2 25 | $34.0M | $68.5M | ||
| Q1 25 | $58.0M | $72.7M | ||
| Q4 24 | $37.5M | $57.9M | ||
| Q3 24 | $33.8M | $54.2M | ||
| Q2 24 | $38.4M | $61.4M | ||
| Q1 24 | — | — |
毛利率HAERBC
| Q4 25 | 59.7% | 44.3% | ||
| Q3 25 | 59.5% | 44.1% | ||
| Q2 25 | 59.8% | 44.8% | ||
| Q1 25 | 58.4% | 44.2% | ||
| Q4 24 | 55.5% | 44.3% | ||
| Q3 24 | 54.2% | 43.7% | ||
| Q2 24 | 52.0% | 45.3% | ||
| Q1 24 | — | 43.1% |
营业利润率HAERBC
| Q4 25 | 19.9% | 22.3% | ||
| Q3 25 | 17.9% | 21.5% | ||
| Q2 25 | 16.8% | 23.2% | ||
| Q1 25 | 21.6% | 23.0% | ||
| Q4 24 | 16.9% | 21.7% | ||
| Q3 24 | 15.0% | 21.6% | ||
| Q2 24 | 11.8% | 24.0% | ||
| Q1 24 | — | 22.8% |
净利率HAERBC
| Q4 25 | 13.2% | 14.6% | ||
| Q3 25 | 11.8% | 13.2% | ||
| Q2 25 | 10.6% | 15.7% | ||
| Q1 25 | 17.5% | 16.6% | ||
| Q4 24 | 10.8% | 14.7% | ||
| Q3 24 | 9.8% | 13.6% | ||
| Q2 24 | 11.4% | 15.1% | ||
| Q1 24 | — | — |
每股收益（稀释后）HAERBC
| Q4 25 | $0.95 | $2.13 | ||
| Q3 25 | $0.81 | $1.90 | ||
| Q2 25 | $0.70 | $2.17 | ||
| Q1 25 | $1.17 | $2.33 | ||
| Q4 24 | $0.74 | $1.82 | ||
| Q3 24 | $0.66 | $1.65 | ||
| Q2 24 | $0.74 | $1.90 | ||
| Q1 24 | — | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $363.4M | $107.6M |
| 总债务越低越好 | $1.2B | $990.2M |
| 股东权益账面价值 | $911.5M | $3.3B |
| 总资产 | $2.5B | $5.1B |
| 负债/权益比越低杠杆越低 | 1.34× | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资HAERBC
| Q4 25 | $363.4M | $107.6M | ||
| Q3 25 | $296.4M | $91.2M | ||
| Q2 25 | $292.9M | $132.9M | ||
| Q1 25 | $306.8M | $36.8M | ||
| Q4 24 | $320.8M | — | ||
| Q3 24 | $299.3M | — | ||
| Q2 24 | $344.4M | $76.8M | ||
| Q1 24 | — | $63.5M |
总债务HAERBC
| Q4 25 | $1.2B | $990.2M | ||
| Q3 25 | $1.2B | $1.1B | ||
| Q2 25 | $1.2B | $915.6M | ||
| Q1 25 | $1.2B | $920.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.2B |
股东权益HAERBC
| Q4 25 | $911.5M | $3.3B | ||
| Q3 25 | $849.2M | $3.2B | ||
| Q2 25 | $882.3M | $3.1B | ||
| Q1 25 | $820.8M | $3.0B | ||
| Q4 24 | $906.9M | $2.9B | ||
| Q3 24 | $878.9M | $2.9B | ||
| Q2 24 | $905.4M | $2.8B | ||
| Q1 24 | — | $2.8B |
总资产HAERBC
| Q4 25 | $2.5B | $5.1B | ||
| Q3 25 | $2.4B | $5.1B | ||
| Q2 25 | $2.5B | $4.8B | ||
| Q1 25 | $2.5B | $4.7B | ||
| Q4 24 | $2.5B | $4.7B | ||
| Q3 24 | $2.5B | $4.7B | ||
| Q2 24 | $2.5B | $4.7B | ||
| Q1 24 | — | $4.7B |
负债/权益比HAERBC
| Q4 25 | 1.34× | 0.30× | ||
| Q3 25 | 1.44× | 0.34× | ||
| Q2 25 | 1.39× | 0.29× | ||
| Q1 25 | 1.49× | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $93.6M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | $87.2M | $99.1M |
| 自由现金流率自由现金流/营收 | 25.7% | 21.5% |
| 资本支出强度资本支出/营收 | 1.9% | 5.0% |
| 现金转化率经营现金流/净利润 | 2.09× | 1.81× |
| 过去12个月自由现金流最近4个季度 | $308.1M | — |
8季度趋势，按日历期对齐
经营现金流HAERBC
| Q4 25 | $93.6M | $122.1M | ||
| Q3 25 | $111.3M | $88.4M | ||
| Q2 25 | $17.4M | $120.0M | ||
| Q1 25 | $116.6M | — | ||
| Q4 24 | $43.8M | $84.0M | ||
| Q3 24 | $48.8M | — | ||
| Q2 24 | $-27.4M | $97.4M | ||
| Q1 24 | — | — |
自由现金流HAERBC
| Q4 25 | $87.2M | $99.1M | ||
| Q3 25 | $106.3M | $71.7M | ||
| Q2 25 | $13.6M | $104.3M | ||
| Q1 25 | $100.9M | — | ||
| Q4 24 | $35.2M | $73.6M | ||
| Q3 24 | $39.4M | — | ||
| Q2 24 | $-33.1M | $88.4M | ||
| Q1 24 | — | — |
自由现金流率HAERBC
| Q4 25 | 25.7% | 21.5% | ||
| Q3 25 | 32.5% | 15.7% | ||
| Q2 25 | 4.2% | 23.9% | ||
| Q1 25 | 30.5% | — | ||
| Q4 24 | 10.1% | 18.7% | ||
| Q3 24 | 11.4% | — | ||
| Q2 24 | -9.8% | 21.8% | ||
| Q1 24 | — | — |
资本支出强度HAERBC
| Q4 25 | 1.9% | 5.0% | ||
| Q3 25 | 1.5% | 3.7% | ||
| Q2 25 | 1.2% | 3.6% | ||
| Q1 25 | 4.7% | 3.2% | ||
| Q4 24 | 2.5% | 2.6% | ||
| Q3 24 | 2.7% | 4.1% | ||
| Q2 24 | 1.7% | 2.2% | ||
| Q1 24 | — | — |
现金转化率HAERBC
| Q4 25 | 2.09× | 1.81× | ||
| Q3 25 | 2.88× | 1.47× | ||
| Q2 25 | 0.51× | 1.75× | ||
| Q1 25 | 2.01× | — | ||
| Q4 24 | 1.17× | 1.45× | ||
| Q3 24 | 1.44× | — | ||
| Q2 24 | -0.71× | 1.59× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
